Heparin use and venous thromboembolism (VTE) among cancer patients receiving chemotherapy with a prior history of VTE.

@article{Cherkowski2009HeparinUA,
  title={Heparin use and venous thromboembolism (VTE) among cancer patients receiving chemotherapy with a prior history of VTE.},
  author={Gina Cherkowski and Julie M Dietrich and F Chen and Jon P. Fryzek and Ken Bridges},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2009},
  volume={27 15_suppl},
  pages={6616}
}
6616 Background: Heparin is an effective treatment option for the prevention of venous thromboembolism (VTE) in cancer patients on chemotherapy. To date, information on the use of both low molecular weight heparin (LMWH) and non-LMWH in cancer patients receiving chemotherapy that have had a prior VTE is lacking. We evaluated heparin treatment patterns as well as the incidence of VTE in a cohort of cancer patients receiving chemotherapy, who have had a VTE prior to their cancer diagnosis… CONTINUE READING

From This Paper

Figures, tables, results, connections, and topics extracted from this paper.
1 Extracted Citations
0 Extracted References
Similar Papers

Similar Papers

Loading similar papers…